Uncategorized

Seattle, WA – November 15, 2024 – Reverba, a global health engagement company specializing in innovative and compliant patient engagement and medical communication solutions for biopharmaceutical companies, today announced that the company has been selected as a Gold Award winner in the 2024 TITAN Business Awards. Reverba was recognized in the Business-to-Business category for ReverbaLINK®,…

Key considerations for effective patient engagement throughout the product lifecycle and clinical trials, and how to leverage this engagement as the industry moves forward Watch this thought-provoking video discussion as our CEO, Cheryl Lubbert shares her insights with Pharmaceutical Executive on best practices for engaging patients from pre-clinical through commercialization stages and beyond. Watch here https://bit.ly/4eXNIm6 or read the…

An innovator ensuring patient voices are heard, driving meaningful innovations in biotech and healthcare through engagement and data. By The Silicon Review Reverba, Co-Founded by Cheryl Lubbert, is a pioneering company dedicated to integrating patient voices into the heart of healthcare innovation. Previously known as Health Perspectives Group, Reverba emerged from Lubbert’s vision of closing…

Experienced expert in scaling business and growing revenue will expand Reverba’s global market reach. Seattle, WA – Reverba, a global health engagement company specializing in innovative and compliant patient engagement and medical communication solutions for biopharmaceutical companies, today announced the appointment of Scott Wolf as the company’s Chief Growth Officer (CGO). In his new role,…

Setting the Trend with Innovative Patient Engagement Strategies By: Cheryl Lubbert, CEO, published in Medhealth Review In the healthcare landscape, patient engagement has become a critical foundational element for achieving positive health outcomes, and a range of healthcare and pharmaceutical companies turn to this important approach to incorporate the patient voice throughout their programs and…

Part 3 of 3: Engaging patients before, during and after the clinical process This blog is part 3 of a series on the impact and benefits of patient involvement with the clinical trial process –  patient willingness to participate in trials, what they can contribute beyond their role as study participant and how to most…

By: Clinical Partnerships Team Part 2 of 3: How patients can improve clinical trial design This blog is part 2 of a series on the impact and benefits of patient involvement with the clinical trial process –  patient willingness to participate in trials, what they can contribute beyond their role as a study participant and…

By: Clinical Partnerships Team Once a promising new drug candidate reaches the clinic, many R&D challenges have already been overcome. But the goal of the clinical trial process to produce quality data brings a new set of challenges. The process of enrolling patients—finding not only the number of patients needed to participate, but the right…

Take a listen to this thought-provoking podcast as our CEO, Cheryl Lubbert shares her insights with pharmaphorum on best practices for engaging patients from pre-clinical through commercialization stages and beyond. Listen here https://lnkd.in/g7xyVECd In the podcast, Reverba CEO Cheryl Lubbert joins host Jonah Comstock to walk through the steps of the product life cycle and…

By: Clinical Trial Partnerships If you are planning clinical trials, Pride Month is the perfect time to take a close look at your diversity initiatives to be sure they encompass inclusion of LGBTQ+ patients in clinical trials. This is an important goal that carries unique challenges. Recent studies reveal that LGBTQ+ community members experience healthcare…